Triamcinolone Acetonide Injection — FDA Drug Shortage

Resolved — Harrow Eye, LLC

The FDA lists a drug shortage record for Triamcinolone Acetonide Injection (injection) from Harrow Eye, LLC with status Resolved. The shortage was first posted on Sep 27, 2021.

Shortage details

Status
Resolved
Company
Harrow Eye, LLC
Package NDC
82667-800-01
Dosage Form
Injection
Presentation
Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)
Initial Posting
Sep 27, 2021

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.